Valion Bio Inc (VBIO) Balance Sheet
VBIO balance sheet, 2025
December 31, 2025 · U.S. dollars$31.6M assets = $14.8M liabilities + $16.8M equity
Both columns are drawn to the same scale: what VBIO owns equals what it owes plus shareholders’ equity. Hover a block for its value.
VBIO financial health
Descriptive bands, not a rating. Fiscal 2025.
VBIO balance sheet trends, 2015–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $134,8002015 | $31.6M2025 | +83.4%/yr | |
| Total liabilities | $652,9602015 | $14.8M2025 | +41.5%/yr | |
| Shareholders’ equity | −$518,1652015 | $16.8M2025 | — | |
| Cash & short-term investments | $95,4302015 | $12.6M2025 | +72.1%/yr | |
| Total debt | $125,6792019 | $6.5M2025 | +92.8%/yr | |
| Net cash (debt) | $2.2M2019 | $6.2M2025 | +$4.0M | |
| Working capital | −$518,1602015 | $12.4M2025 | +$12.9M | |
| Book value per share | −$0.072015 | $14.542025 | — | |
| Debt / equity | 0.052019 | 0.382025 | +0.33 | |
| Shares outstanding | 7.5M2015 | 1.2M2025 | −18.8%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
VBIO assets
VBIO liabilities and equity
VBIO debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
VBIO balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $12.6M | $2.0M | $3.4M | $3.5M | $13.0M | $1.0M | $2.3M | $656,290 | $1.2M | $95,430 |
| Cash & equivalents | $12.6M | $2.0M | $3.4M | $3.5M | $13.0M | $1.0M | $2.3M | $656,290 | $1.2M | $95,430 |
| Receivables | $1,000 | $69,000 | $174,000 | $107,000 | $92,000 | $52,000 | $13,000 | $13,840 | $19,200 | $30,400 |
| Inventory | $0 | $319,000 | $756,000 | $863,000 | $429,000 | $241,000 | $475,000 | $0 | $0 | $6,470 |
| Other current assets | $360,000 | $249,000 | $327,000 | $819,000 | $793,000 | $160,000 | $175,000 | $5,660 | $3,050 | $2,500 |
| Total current assets | $13.0M | $2.6M | $4.7M | $5.3M | $14.3M | $1.5M | $3.0M | $675,790 | $1.2M | $134,800 |
| Property, plant & equipment (net) | $16.1M | $2,000 | $471,000 | $535,000 | $698,000 | $19,000 | $27,000 | $0 | $0 | $0 |
| Goodwill & intangible assets | $2.2M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $260,000 | $166,000 | $34,000 | $34,000 | $49,000 | $15,000 | $23,000 | $0 | $0 | $0 |
| Total assets | $31.6M | $2.8M | $5.2M | $5.9M | $15.0M | $1.5M | $3.0M | $675,790 | $1.2M | $134,800 |
| Liabilities | ||||||||||
| Accounts payable | $264,000 | $125,000 | $713,000 | $1.3M | $789,000 | $370,000 | $369,000 | — | — | — |
| Short-term debt | $500,000 | — | $193,000 | $163,000 | $163,000 | $36,000 | $125,679 | — | — | — |
| Deferred revenue | — | — | — | — | — | $16,000 | $1,000 | — | — | — |
| Total current liabilities | $646,000 | $272,000 | $1.4M | $1.9M | $1.2M | $1.3M | $653,000 | $353,520 | $800,650 | $652,960 |
| Long-term debt | $6.5M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | — | $0 | $369,000 | $530,000 | — | — | — | — | — | — |
| Other long-term liabilities | $7.7M | $0 | $176,000 | $367,000 | $544,999 | $1.4M | $0 | $0 | $0 | $0 |
| Total liabilities | $14.8M | $272,000 | $1.6M | $2.2M | $1.8M | $2.7M | $653,000 | $353,520 | $800,650 | $652,960 |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $2,000 | $1,000 | — | — | $1,000 | $1,000 | $1,000 | $24,080 | $22,210 | $179,090 |
| Retained earnings (deficit) | −$52.6M | −$43.5M | −$37.9M | −$29.6M | −$19.5M | −$11.1M | −$7.4M | −$22.0M | −$17.7M | −$12.5M |
| Total shareholders' equity | $16.8M | $2.5M | $3.6M | $3.6M | $13.3M | −$1.2M | $2.4M | $322,274 | $374,368 | −$518,165 |
| Key figures | ||||||||||
| Total debt | $6.5M | — | $369,000 | $530,000 | $708,000 | $1.5M | $125,679 | — | — | — |
| Net cash (debt) | $6.2M | — | $3.0M | $3.0M | $12.3M | −$425,000 | $2.2M | — | — | — |
| Working capital | $12.4M | $2.4M | $3.3M | $3.4M | $13.1M | $222,000 | $2.3M | $322,270 | $374,370 | −$518,160 |
| Tangible book value | $14.6M | $2.5M | $3.6M | $3.6M | $13.3M | −$1.2M | $2.4M | $322,274 | $374,368 | −$518,165 |
| Book value per share | $14.54 | — | — | — | — | — | — | — | — | −$0.07 |
| Shares outstanding | 1.2M | — | — | — | — | — | — | — | — | 7.5M |
| Current ratio | 20.13 | 9.70 | 3.32 | 2.83 | 11.72 | 1.17 | 4.55 | 1.91 | 1.47 | 0.21 |
| Quick ratio | 19.58 | 7.61 | 2.55 | 1.93 | 10.72 | 0.86 | 3.56 | 1.90 | 1.46 | 0.19 |
| Debt / equity | 0.38 | — | 0.10 | 0.15 | 0.05 | — | 0.05 | — | — | — |
| Equity / assets | 53.1% | 90.3% | 69.4% | 61.8% | 88.3% | −76.9% | 78.4% | 47.7% | 31.9% | −384.4% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $2.1M | $7.2M | $12.6M | $3.5M | $1.2M | $669,000 | $2.0M | $2.2M | $3.7M | $1.7M | $3.4M | $5.2M |
| Cash & equivalents | $2.1M | $7.2M | $12.6M | $3.5M | $1.2M | $669,000 | $2.0M | $2.2M | $3.7M | $1.7M | $3.4M | $5.2M |
| Receivables | $1.4M | $950,114 | $0 | $19,000 | $13,000 | $13,000 | $69,000 | $9,000 | $16,000 | $74,000 | $174,000 | $131,000 |
| Inventory | $750,000 | $750,000 | $0 | $4,000 | $283,000 | $306,000 | $319,000 | $731,000 | $766,000 | $774,000 | $756,000 | $928,000 |
| Other current assets | $0 | $0 | $361,000 | $267,000 | $362,000 | $273,000 | $249,001 | $234,000 | $188,000 | $250,000 | $327,000 | $227,000 |
| Total current assets | $3.4M | $8.7M | $13.0M | $3.7M | $1.8M | $1.3M | $2.6M | $3.2M | $4.7M | $2.8M | $4.7M | $6.5M |
| Property, plant & equipment (net) | $22.2M | $22.7M | $16.1M | $12,000 | $120,000 | $118,000 | $119,000 | $119,000 | $120,000 | $425,000 | $471,000 | $518,000 |
| Goodwill & intangible assets | $9.2M | $5.7M | $2.2M | $2.2M | $2.2M | $2.2M | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $1.1M | $260,000 | $234,000 | $303,000 | $172,000 | $49,000 | $112,000 | $0 | $95,000 | $131,000 | $34,000 |
| Total assets | $32.5M | $38.2M | $31.6M | $6.2M | $4.5M | $3.8M | $2.8M | $3.4M | $4.8M | $3.3M | $5.3M | $7.0M |
| Liabilities | ||||||||||||
| Accounts payable | $639,000 | $629,000 | $264,000 | $465,000 | $234,000 | $438,000 | $125,000 | $333,000 | $446,000 | $547,000 | $713,000 | $638,000 |
| Short-term debt | $533,000 | $492,000 | — | $300,000 | — | — | — | — | — | $180,000 | $193,000 | $173,000 |
| Deferred revenue | — | — | — | — | — | — | $2,000 | — | — | — | $8,000 | — |
| Total current liabilities | $3.0M | $2.6M | $646,000 | $638,000 | $821,000 | $741,000 | $272,000 | $560,000 | $591,000 | $992,000 | $1.4M | $1.0M |
| Long-term debt | $7.4M | $6.9M | $6.5M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $10.0M | $10.1M | — | — | — | — | $0 | — | — | — | — | — |
| Other long-term liabilities | $10.2M | $17.6M | $7.7M | $46.3M | $0 | $0 | $0 | $0 | $0 | $141,000 | $272,999 | $242,000 |
| Total liabilities | $20.6M | $27.2M | $14.8M | $638,000 | $821,000 | $741,000 | $272,000 | $560,000 | $591,000 | $1.1M | $1.7M | $1.2M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $2,000 | $2,000 | $2,000 | $2,000 | $1,000 | $1,000 | $1,000 | $1,000 | $1,000 | — | — | — |
| Retained earnings (deficit) | −$66.5M | −$59.0M | −$52.6M | −$49.6M | −$47.0M | −$45.0M | −$43.5M | −$42.1M | −$40.6M | −$39.4M | −$37.9M | −$35.6M |
| Total shareholders' equity | $11.9M | $11.1M | $16.8M | $5.6M | $3.7M | $3.0M | $2.5M | $2.8M | $4.2M | $2.2M | $3.6M | $5.8M |
| Key figures | ||||||||||||
| Total debt | $17.4M | $17.0M | $6.5M | $300,000 | — | — | — | — | — | $321,000 | $369,000 | $415,000 |
| Net cash (debt) | −$15.3M | −$9.8M | $6.2M | $3.1M | — | — | — | — | — | $1.3M | $3.0M | $4.8M |
| Working capital | $336,000 | $6.0M | $12.4M | $3.1M | $1.0M | $520,000 | $2.4M | $2.6M | $4.1M | $1.8M | $3.3M | $5.5M |
| Tangible book value | $2.7M | $5.4M | $14.6M | $3.3M | $1.4M | $810,000 | $2.5M | $2.8M | $4.2M | $2.2M | $3.6M | $5.8M |
| Book value per share | — | $3.84 | — | $4.23 | $4.18 | — | $4.55 | — | — | — | — | — |
| Shares outstanding | — | 2.9M | — | 1.3M | 881K | — | 557K | — | — | — | — | — |
| Current ratio | 1.11 | 3.31 | 20.13 | 5.86 | 2.24 | 1.70 | 9.70 | 5.65 | 7.89 | 2.79 | 3.32 | 6.46 |
| Quick ratio | 1.16 | 3.12 | 19.57 | 5.44 | 1.46 | 0.92 | 7.61 | 3.92 | 6.28 | 1.76 | 2.55 | 5.30 |
| Debt / equity | 1.46 | 1.54 | 0.38 | 0.05 | — | — | — | — | — | 0.15 | 0.10 | 0.07 |
| Equity / assets | 36.6% | 28.9% | 53.1% | 89.8% | 81.8% | 80.4% | 90.3% | 83.5% | 87.6% | 65.5% | 68.1% | 82.3% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 30, 2026); data from EODHD.
VBIO financial position
At the end of fiscal 2025 (December 31, 2025), Valion Bio had total assets of $31.6 million (up 1,026.0% from a year earlier), total liabilities of $14.8 million and shareholders' equity of $16.8 million. It held $12.6 million in cash and short-term investments against $6.5 million of debt, a net cash position of $6.2 million. Its current ratio was 20.13. In the latest quarter (ended June 30, 2026) total assets were $32.5 million and equity $11.9 million.
Related: VBIO income statement, VBIO cash flow statement, VBIO key metrics. See the VBIO stock overview for the latest quote and news.
VBIO balance sheet FAQ
What are Valion Bio's total assets?
Valion Bio reported total assets of $31.6 million at the end of fiscal 2025 (December 31, 2025), compared with $2.8 million a year earlier.
How much debt does Valion Bio have?
Valion Bio had $6.5 million of total debt at the end of fiscal 2025, including short-term borrowings. Its debt-to-equity ratio was 0.38.
How much cash does Valion Bio have?
Valion Bio held $12.6 million in cash and short-term investments at the end of fiscal 2025; with $6.5 million of debt that is net cash of $6.2 million.
What is Valion Bio's book value?
Valion Bio's shareholders' equity (book value) was $16.8 million at the end of fiscal 2025, or $14.54 per share.
What is Valion Bio's current ratio?
Valion Bio had current assets of $13.0 million and current liabilities of $0.6 million, a current ratio of 20.13 (it can cover its short-term obligations).
How much goodwill does Valion Bio have?
Valion Bio carried $2.2 million of goodwill and intangible assets, 7.1% of total assets, at the end of fiscal 2025.